Vardhman Life Sciences Private Limited - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 2007.

2007 New Delhi, Delhi, India Active

Last Updated: January 06, 2026

About Vardhman Life Sciences Private Limited

Vardhman Life Sciences Private Limited, a active private limited company, was established on 13 December 2007 in New Delhi, Delhi, India. Engaging in api manufacturers within the pharma sector, it holds CIN: U24230DL2007PTC171395. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹30.00 Cr and a paid-up capital of ₹24.34 Cr.

Formerly known as Dewan Buildcon Private Limited. It upholds a active non-compliant status. Its leadership includes Vivek Gupta (Director), Suyog Jain (Director), Rajinder Singh Gujral (Director). Past directors included Sushil Kumar Singla, Ravinder Kumar Goel, Sanjay Kumar Randhar. It holds ₹175.00 Cr open charges and no settled loans. Its latest AGM occurred on 21 March 2017, with the balance sheet filed on 31 March 2015. It is based at 78, 1St Floor Sandesh Vihar, Pitampura, New Delhi, Delhi, 110034.

Company Details

CIN/LLPIN
U24230DL2007PTC171395
Registration Number
171395
Incorporation Date
13 December 2007
Authorized Capital
₹30.00 Cr
Paid-Up Capital
₹24.34 Cr
ROC Code
Roc Delhi
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 30.00 Cr as on 06-01-2026
Paid Up Capital ₹ 24.34 Cr as on 06-01-2026
Company Age 18 Year, 2 Months
Last Filing with ROC 31 Mar 2015
Open Charges ₹ 175.00 Cr as on 06-01-2026
Revenue Growth **** -65.83% (FY 2015)
Profit Growth **** -79.52% (FY 2015)
Ebitda **** 17.11% (FY 2015)
Net Worth -105.37% (FY 2015)
Total Assets -17.31% (FY 2015)

Comprehensive Company Insights

Explore comprehensive insights into Vardhman Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Vardhman Life Sciences Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Vivek Gupta	Director	20 Apr 2010	Current
Suyog Jain	Director	20 Apr 2010	Current
Rajinder Singh Gujral	Director	20 Apr 2010	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	23 Mar 2012	Past
Pramod Abcsdd	Director	15 Dec 2009	Past
Pramod Abcsdd	Additional Director	28 Sep 2012	Past
Pramod Abcsdd	Director	26 May 2010	Past
Pramod Abcsdd	Director	26 May 2010	Past
Pramod Abcsdd	Director	26 Aug 2008	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Vardhman Life Sciences.

Vardhman Life Sciences Private Limited, for the financial year ended 2015, experienced significant reduction in revenue, with a 65.83% decrease. The company also saw a substantial fall in profitability, with a 79.52% decrease in profit. The company's net worth observed a substantial decline by a decrease of 105.37%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-65.83%

*******

Revenue from Operations

*******

Total Assets

*******

-17.31%

*******

Profit or Loss

*******

-79.52%

*******

Net Worth

*******

-105.37%

*******

EBITDA

*******

17.11%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Vardhman Life Sciences?

In 2015, Vardhman Life Sciences had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹1,750,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

Edelweiss Asset Reconstruction Company Limited : 120.00 Cr
Others : 55.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
16 Dec 2010	Edelweiss Asset Reconstruction Company Limited	₹40.00 Cr	Open
15 Dec 2010	Edelweiss Asset Reconstruction Company Limited	₹40.00 Cr	Open
23 Nov 2010	Edelweiss Asset Reconstruction Company Limited	₹40.00 Cr	Open
29 Oct 2010	Others	₹55.00 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Vardhman Life Sciences?

Vardhman Life Sciences has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Vardhman Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vardhman Life Sciences's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Vardhman Life Sciences

Recent Activity within the Organization

Annual General Meeting

The activity Vardhman Life Sciences Private Limited last Annual general meeting of members was held on 21 Mar 2017 as per latest MCA records. was completed.
21 Mar 2017
Balance Sheet

Progress on Vardhman Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2015 with Roc Delhi. was documented.
31 Mar 2015
Charges

A charge with Edelweiss Asset Reconstruction Company Limited of Rs. 40.00 Cr registered on 23 Nov 2010 with Charge ID 10255360 was modified on 04 Mar 2015. was recorded as a recent event.
04 Mar 2015
Charges

A charge with Edelweiss Asset Reconstruction Company Limited of Rs. 40.00 Cr registered on 15 Dec 2010 with Charge ID 10267193 was modified on 21 Jul 2014. was recorded as a recent event.
21 Jul 2014
Charges

A charge with Edelweiss Asset Reconstruction Company Limited of Rs. 40.00 Cr registered on 16 Dec 2010 with Charge ID 10260447 was modified on 25 Jun 2014. was recorded as a recent event.
25 Jun 2014
Charges

Progress on A charge with Others of Rs. 55.00 Cr registered on 29 Oct 2010 with Charge ID 10250363 was modified on 28 Mar 2014. was documented.
28 Mar 2014

Explore recent activity and updates - View Recent Activity